Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kagoshima Shinsangyo Sousei Investment is a regional venture capital fund based in Kagoshima, Japan, established to support the creation and growth of innovative startups within the prefecture. The fund is managed by Kagoshima Capital, which is a wholly-owned subsidiary of The Kagoshima Bank. It focuses on providing venture capital to early-stage companies, including those emerging from research at Kagoshima University, across sectors such as life sciences, healthcare, and technology. By offering both financial investment and management consultancy, the fund aims to bridge the gap between local academic innovation and commercial success. Its activities are central to the regional economic revitalization strategy of the Kagoshima Bank Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kagoshima Shinsangyo Sousei Investment.